TABLE 33.11.
Treatment Week | Drug, Dosage, and Route |
---|---|
1 | Vincristine, 0.5–0.7 mg/m2, IV l-Asparaginase, 400 Units/kg, SC Prednisolone, 2.0 mg/kg, PO |
2 | Cyclophosphamide 200 mg/m2, PO Prednisolone, 2.0 mg/kg, PO |
3 | Vincristine, 0.5–0.7 mg/m2, IV Prednisolone, 1.0 mg/kg, PO |
4 | Doxorubicin, 25 mg/m2, IV Prednisolone, 1.0 mg/kg, POa |
6 | Vincristine, 0.5–0.7 mg/m2, IV |
7 | Cyclophosphamide 200 mg/m2, PO |
8 | Vincristine, 0.5–0.7 mg/m2, IV |
9b | Doxorubicin, 25 mg/m2, IV |
11 | Vincristine, 0.5–0.7 mg/m2, IV |
13 | Cyclophosphamide 200 mg/m2, PO |
15 | Vincristine, 0.5–0.7 mg/m2, IV |
17 | Doxorubicin, 25 mg/m2, IV |
19 | Vincristine, 0.5–0.7 mg/m2, IV |
21 | Cyclophosphamide 200 mg/m2, PO |
23 | Vincristine, 0.5–0.7 mg/m2, IV |
25c | Doxorubicin, 25 mg/m2, IV |
CHOP, Combinations of cyclophosphamide (C), doxorubicin (H, hydroxydaunorubicin), vincristine (O, Oncovin), and prednisolone (P); IV, intravenous; PO, by mouth; SQ, subcutaneous.
Note: A complete blood count (CBC) should be performed before each chemotherapy. If neutrophils are <1500 cells/μL, wait 5–7 days, repeat CBC, then administer the drug if neutrophils have risen above the 1500 cell/μL cutoff.
Prednisolone is continued (1 mg/kg, PO) every other day from this point on.
If in complete remission at week 9, continue to week 11.
If in complete remission at week 25, therapy is discontinued after this doxorubicin, and cat is rechecked monthly for recurrence.